# Top 50 Health Care Angel Investors in Israel in May 2026

## Marius Nacht
- Type: Angel
- Location: Tel Aviv-yafo, Tel Aviv, Israel
- Relevant deals: 5
- Stages: Series A, Seed, Series B
- Focus: Artificial Intelligence, Machine Learning, Health Care

Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point.
Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.

## Howard Morgan
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 3
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Health Care

Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley.
Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal.
Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences.
Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.

## Ran Tuttnauer
- Type: Angel
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Health Care, Big Data, Medical Device

Ran Tuttnauer

## Prof. Rafael Beyar
- Type: Angel
- Location: Haifa, Hefa, Israel
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Medical, Medical Device, Machine Learning

Prof. Rafael Beyar

## Shmuel Cabilly
- Type: Angel
- Location: Rehovot, HaMerkaz, Israel
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Medical, Artificial Intelligence

Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.

## Moshe Gaon
- Type: Angel
- Relevant deals: 2
- Stages: Seed, Series A, Convertible Note
- Focus: Advertising, Association, Social Media Marketing

Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.

## Zohar Gilon
- Type: Angel
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Internet, Medical Device

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

## Dov Moran
- Type: Angel
- Location: Kfar Saba, HaMerkaz, Israel
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Semiconductor, Hardware, Health Care

Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.

## Yehuda Zisapel
- Type: Angel
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Medical Device, Medical, Health Care

Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.

## Assaf Wand
- Type: Angel
- Location: Palo Alto, California, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Insurance, Health Care, Information Technology

Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi (Sold to Urbio) as a Founder and CEO. Assaf Wand attended Reichman University (IDC Herzliya).

## Yaron Samid
- Type: Angel
- Location: Ramat Hasharon, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Apps, Cyber Security

Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.

## Ron C
- Type: Angel
- Relevant deals: 2
- Stages: Seed
- Focus: Health Care, Therapeutics, Medical Device

Ron C

## Shimon Eckhouse
- Type: Angel
- Relevant deals: 2
- Stages: Seed
- Focus: Medical, Biotechnology, Fitness

Shimon Eckhouse

## Mazal CB
- Type: Angel
- Relevant deals: 2
- Stages: Seed
- Focus: Health Care, Therapeutics, Medical Device

Mazal CB

## Lewis Pell
- Type: Angel
- Relevant deals: 1
- Focus: Health Care, Therapeutics, Medical Device

Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.

## Avishai Abrahami
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Internet, Social Media

Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.

## Ronald Cohen
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Software, Artificial Intelligence

Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.

## Lyndon Babtiste
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: mHealth, Blockchain, Health Care

Lyndon Babtiste

## Beni Nofech
- Type: Angel
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 1
- Stages: Pre-Seed, Series A
- Focus: Food and Beverage, Food Processing, Nutrition

Beni Nofech is a food-tech investor.

## Lily Sarafan
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Wellness, Enterprise Software

Lily Sarafan is the Executive Chair of TheKey. She is also an Operating Partner at Cota Capital.An active Stanford alum, Lily serves on the Stanford Alumni Association Board of Directors, the Freeman Spogli Institute Council, and the Stanford Undergraduate Education Cabinet. She is also Founding Partner of Project BIG: The Stanford Brain ImmuneGut Initiative. Lily's board service extends to other high-impact nonprofits including the Women's Alzheimer's Movement and the BerkeleyHaas Center for Innovation Economies, where she is board chair. An appointee to the California Governor’s Alzheimer's Task Force, Lily serves in various leadership roles to advance economic development, civic engagement, and precision health.Lily holds an M.S. in Management Science and Engineering and B.S. in Science, Technology, and Society from Stanford University, where she was Eben Tisdale Fellow and Class President. She has been named Ernst & Young Entrepreneur of the Year, Women Health Care Executives Woman of the Year, and a Silicon Valley 40 Under 40. Lily is a Member of Young Presidents' Organization, a Term Member of the Council on Foreign Relations, a Henry Crown Fellow of the Aspen Institute, and a World Economic Forum Young Global Leader.

## David Agus
- Type: Angel
- Location: Beverly Hills, California, United States
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Health Diagnostics, Artificial Intelligence

David Agus is an American physician and a New York Times bestselling author. He is a Professor of Medicine and Engineering at the University of Southern California. He is co-founder of Navigenics, a personalized medicine company and Applied Proteomics, as well as a CBS News contributor.

## Rick Klausner
- Type: Angel
- Location: San Francisco Bay Area, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series E
- Focus: Biotechnology, Therapeutics, Life Science

Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.

## Moshe Shoham
- Type: Angel
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Medical, Health Care, Artificial Intelligence

Moshe Shoham

## Alan Patricof
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Financial Services, Finance

Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.

## Sake Bosch
- Type: Angel
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, E-Commerce, Food and Beverage

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

## Nancy Spielberg
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Wearables, Health Care, Machine Learning

Nancy Spielberg - Advisory Board Member @ The Elegant Monkeys

## Zohar Zisapel
- Type: Angel
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Cyber Security, Information Technology, Security

Zohar Zisapel

## Daniel Koss
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical Device, Clinical Trials, Health Diagnostics

Daniel Koss is an individual investor.

## Haim Chizic
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical Device, Clinical Trials, Health Diagnostics

Haim Chizic is an individual investor.

## Tzachi Arabov
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical Device, Clinical Trials, Health Diagnostics

Tzachi Arabov is a owner of ACRO.

## Joshua Riff
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Wellness, Analytics

Josh Riff is the co-founder of Included Health.

## Anne Wojcicki
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

## Ole T. Jensen
- Type: Angel
- Relevant deals: 1
- Focus: Biotechnology, Medical Device

Ole T. Jensen

## Romain Afflelou
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, FinTech, Software

Romain spearheaded the digital strategy of Alain Afflelou Group before becoming an investor in numerous start-ups. He uses his fine-tuned analysis skills to support and invest in innovative start-ups. In addition to being a major shareholder and Co founder of Cosmo Connected a French start-up specialized in connected objects related to security andmobility.Romain is Director and Board member of Multiwave Technologies /develops breakthrough metamaterial technologies to improve people's lives.Serial investor in +50Tech companies6over6 (Acquired by 1-800 contacts)
Cityscoot
Clay Inc VR
Cowboy Bike
Epicery
Everoad (Ex Convargo)
Fithouse
Fré Skincare
Fokoya
Guillotine Vodka
Klassroom
Laminate Technologies
MeetFabric
Molotov TV
Multiwave Technologies
Nestor
Octopus
Officeriders
Onoff telecom
Pledg
Quiqup
Universal Standard
Shapr
Spendesk
Zipdrug...(Acquire by Anthem Pharmacy)

## Chris Mansi
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Medical, Software

Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, buildingand supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.

## Brock Weatherup
- Type: Angel
- Location: San Diego, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: EdTech, Medical, mHealth

Brock Weatherup is the CEO/Founder of Metamorphosis Partners driving enterprise value through innovation in the $80B pet industry focused on the consumer. Brock was most recently the EVP of Strategic Innovation & Digital Experience at Petco. Previously he was CEO & CoFounder of PetCoach (acquired by Petco) - revolutionizing the PetHealth Care experience. Brock is a CEO, entrepreneur, angel investor, builder of enterprise value and passionate advocate about the consumer and their interactions with digital media & Ecommerce. Brock is also managing partner of Atai Ventures angel investments, co-founder of ICONYC (www.iconyclabs.com) an early stage NYC based Israeli accelerator, investor/advisor/board member for 7+ startups - VeryApt, SideCar, Social Ladder, Ethology and an industry advisor for VC firms EQT Partners, MissionOG & SafeGuard. Previously Brock was SVP/Chief Digital Officer of Petsmart after selling Pet360 where he was CEO the prior 5 years. Brock was also CEO of Fathead and held several leadership positions with InterActiveCorp (Ticketmaster, Match.com, CitySearch, ReserveAmerica). A graduate of University of Colorado Boulder, sits as a board member of the Nature Conservancy – Adirondacks, father of two amazing girls and pet owner to my 4yr old retriever named...Boulder.

## Ariel Yaar
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, Health Care, CRM

Ariel Yaar - VP Research and Development @ Readz

## Robert Nelsen
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than 100 companies, including nineteen which have reached valuations exceeding $1 billion. His seed and early-stage investments include Illumina (ILMN);Alnylam Pharmaceuticals (ALNY); Juno Therapeutics (JUNO); Unity Biotechnology (UBX); Sienna Biopharmaceuticals (SNNA); Vir Biotechnology, Agios Pharmaceuticals (AGIO); Sage Therapeutics (SAGE); GRAIL, Ikaria; Kythera Biopharmaceuticals (KYTH), Receptos (RCPT); Aviron (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics, KSQ Therapeutics, Beam Therapeutics, NetBot; Bluebird Bio (BLUE); R2 Technology; XenoPort (XNPT); Caliper Life Sciences (CALP); Trubion Pharmaceuticals (TRBN); Adolor (ADLR); deCODE Genetics; Array BioPharma (ARRY); Editas (EDIT), IDUN Pharmaceuticals; Classmates.com; Hua Medicine; Fate Therapeutics (FATE); WuxiNextCODE; and Everyday Learning Corporation.Mr. Nelsen is a director of Vir Bio, GRAIL, Sienna Biopharmaceuticals, Beam Therapeutics, Unity Biotechnology, Denali Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and was a director of the National Venture Capital Association. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.

## Gigi Levy Weiss
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, SaaS

Gigi Levy Weiss is the General Partner at NFX. He attended Tel Aviv University and the Finance Department - Kellogg School of Management.

## Noam Solomon
- Type: Angel
- Location: Tel Aviv-yafo, Tel Aviv, Israel
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Wellness, Health Care

Noam Soloman is the CEO and co-founder at Immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data setin the world for clinical immunological data. Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam is a double Ph.D., and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.

## Shahar Tzafrir
- Type: Angel
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Information Technology

Shahar is a Managing Partner at TLV Partners I, II, III.
Shahar is a board member in Aidoc, Buildots, Canopy Immuno-Therapeutics, Deepcure, EverAfterAI, Granulate, Guesty, Hunterz, Immunai, Odo, ScyllaDB, Shookit, Silverfort.Before joining TLV Partners Shahar was a General Partner at Magma Venture Partners III and IV and was a board member inAidoc, Applitools, CloudEndure (acquired by Amazon), Coretigo, Guesty, Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, Tonkean

## Larry Ellison
- Type: Angel
- Location: Redwood Shores, California, United States
- Relevant deals: 1
- Stages: Series C, Series G
- Focus: Software, Health Care, Biotechnology

Larry Ellison is executive chairman of Oracle Corporation and chief technology officer. He founded the company in 1977 and served as CEO until September 2014. He also races sailboats, flies planes, and plays tennis and guitar.

## Rafi Gidron
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Angel, Series B
- Focus: Artificial Intelligence, Cyber Security, Analytics

Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.

## Danny Hadar
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Series B
- Focus: Software, Artificial Intelligence, Machine Learning

For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.

## Sacha Levy
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Debt Financing
- Focus: Software, Health Care, mHealth

HealthTech angel

## Bradley M. Bloom
- Type: Angel
- Location: Boston, Massachusetts, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Food and Beverage, Sports, Fitness

Bradley M. Bloom is the Managing Director at Berkshire Partners.

## David E. Weekly
- Type: Angel
- Location: Redwood City, California, United States
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: Robotics, Drones, Aerospace

David E. Weekly is the Founder and CEO of Medcorder and he was the Founding Director of Hacker Dojo. He has a bachelor's degree in Computer Science from Stanford University.

## Eyal Gura
- Type: Angel
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, Mobile, Artificial Intelligence

Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).

## Vivek Garipalli
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Machine Learning

Vivek Garipalli was the Co-Founder, CEO, and Board Member of Clover Health. He attended Emory University.

## Amir Gross
- Type: Angel
- Relevant deals: 1
- Focus: Medical, Health Care, Medical Device

Amir Gross is the CEO of Cardiovalve.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co